U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 641

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr12:52307106-52307111
GRCh38:
Chr12:51913322-51913327
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Pathogeniccriteria provided, single submitter
2.
GRCh37:
Chr12:52306259-52310037
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Uncertain significance
(Jul 14, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr12:52309800-52310037
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Aug 20, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr12:52309881
GRCh38:
Chr12:51916097
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Oct 4, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr12:52312883
GRCh38:
Chr12:51919099
ACVRL1R350Q, R266Q, R454Q, R284Q, R402QTelangiectasia, hereditary hemorrhagic, type 2Uncertain significance
(Jul 27, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr12:52309292
GRCh38:
Chr12:51915508
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Feb 13, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr12:52309969
GRCh38:
Chr12:51916185
ACVRL1A212T, A400T, A296TTelangiectasia, hereditary hemorrhagic, type 2Likely pathogenic
(May 21, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr12:52307498
GRCh38:
Chr12:51913714
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Sep 24, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr12:52309963
GRCh38:
Chr12:51916179
ACVRL1I210V, I294V, I398VTelangiectasia, hereditary hemorrhagic, type 2Uncertain significance
(May 21, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr12:52307397
GRCh38:
Chr12:51913613
ACVRL1L123QTelangiectasia, hereditary hemorrhagic, type 2Uncertain significance
(Jan 16, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr12:52309289
GRCh38:
Chr12:51915505
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely pathogenic
(Sep 24, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr12:52309224
GRCh38:
Chr12:51915440
ACVRL1D226Y, D330Y, D142YTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Sep 9, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr12:52309097-52309098
GRCh38:
Chr12:51915313-51915314
ACVRL1L289fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Aug 18, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr12:52312837
GRCh38:
Chr12:51919053
ACVRL1K269*, K335*, K387*, K439*, K251*Telangiectasia, hereditary hemorrhagic, type 2Pathogenic
(May 5, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr12:52306972
GRCh38:
Chr12:51913188
ACVRL1C51STelangiectasia, hereditary hemorrhagic, type 2Likely pathogenic
(May 1, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr12:52307745
GRCh38:
Chr12:51913961
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Uncertain significance
(Feb 23, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr12:52312782
GRCh38:
Chr12:51918998
ACVRL1Y421fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Feb 21, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr12:52308285
GRCh38:
Chr12:51914501
ACVRL1I126F, I230F, I42FTelangiectasia, hereditary hemorrhagic, type 2Likely pathogenic
(Sep 10, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr12:52309002
GRCh38:
Chr12:51915218
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Feb 1, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr12:52309083
GRCh38:
Chr12:51915299
ACVRL1G95S, G179S, G283STelangiectasia, hereditary hemorrhagic, type 2Uncertain significance
(Mar 26, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr12:52307092
GRCh38:
Chr12:51913308
ACVRL1D91NTelangiectasia, hereditary hemorrhagic, type 2Uncertain significance
(Apr 22, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr12:52307334
GRCh38:
Chr12:51913550
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Mar 28, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr12:52307528
GRCh38:
Chr12:51913744
ACVRL1S167PTelangiectasia, hereditary hemorrhagic, type 2Uncertain significance
(Jul 5, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr12:52309133
GRCh38:
Chr12:51915349
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Jul 13, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr12:52309174
GRCh38:
Chr12:51915390
ACVRL1L125R, L209R, L313RTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Aug 5, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr12:52306874
GRCh38:
Chr12:51913090
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Sep 27, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr12:52307505
GRCh38:
Chr12:51913721
ACVRL1E159GTelangiectasia, hereditary hemorrhagic, type 2Uncertain significance
(Dec 25, 2021)
criteria provided, single submitter
28.
GRCh37:
Chr12:52314570-52314571
GRCh38:
Chr12:51920786-51920787
ACVRL1E470fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Oct 25, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr12:52307458
GRCh38:
Chr12:51913674
ACVRL1R144fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Oct 23, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr12:52309226
GRCh38:
Chr12:51915442
ACVRL1D142E, D226E, D330ETelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Oct 23, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr12:52308270
GRCh38:
Chr12:51914486
ACVRL1S225fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Oct 22, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr12:52308247
GRCh38:
Chr12:51914463
ACVRL1W217fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Sep 20, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr12:52309074-52309078
GRCh38:
Chr12:51915290-51915294
ACVRL1H280fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Sep 16, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr12:52309246
GRCh38:
Chr12:51915462
ACVRL1L337R, L233R, L149RTelangiectasia, hereditary hemorrhagic, type 2Uncertain significance
(Sep 10, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr12:52309271
GRCh38:
Chr12:51915487
ACVRL1C345*, C157*, C241*Telangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Sep 10, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr12:52309198-52309199
GRCh38:
Chr12:51915414-51915415
ACVRL1Q321fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Aug 22, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr12:52309967
GRCh38:
Chr12:51916183
ACVRL1A400fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Jul 14, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr12:52307851
GRCh38:
Chr12:51914067
ACVRL1C207GTelangiectasia, hereditary hemorrhagic, type 2Uncertain significance
(Jun 29, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr12:52309048
GRCh38:
Chr12:51915264
ACVRL1T167R, T271R, T83RTelangiectasia, hereditary hemorrhagic, type 2Uncertain significance
(Jun 1, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr12:52309277-52309278
GRCh38:
Chr12:51915493-51915494
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Uncertain significance
(May 27, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr12:52309210
GRCh38:
Chr12:51915426
ACVRL1A137G, A221G, A325GTelangiectasia, hereditary hemorrhagic, type 2Uncertain significance
(Oct 24, 2021)
criteria provided, single submitter
42.
GRCh37:
Chr12:52306953
GRCh38:
Chr12:51913169
ACVRL1C46fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Oct 22, 2019)
criteria provided, single submitter
43.
GRCh37:
Chr12:52309113
GRCh38:
Chr12:51915329
ACVRL1T293fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Jul 20, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr12:52306320
GRCh38:
Chr12:51912536
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely pathogenic
(Feb 5, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr12:52312881
GRCh38:
Chr12:51919097
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Feb 23, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr12:52309932
GRCh38:
Chr12:51916148
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Jun 26, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr12:52307004
GRCh38:
Chr12:51913220
ACVRL1R61STelangiectasia, hereditary hemorrhagic, type 2Uncertain significance
(Jun 16, 2021)
criteria provided, single submitter
48.
GRCh37:
Chr12:52306934
GRCh38:
Chr12:51913150
ACVRL1S38NTelangiectasia, hereditary hemorrhagic, type 2Uncertain significance
(Sep 4, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr12:52309280
GRCh38:
Chr12:51915496
ACVRL1D160E, D244E, D348ETelangiectasia, hereditary hemorrhagic, type 2Likely pathogenic
(Apr 29, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr12:52307561
GRCh38:
Chr12:51913777
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Jan 26, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr12:52306921
GRCh38:
Chr12:51913137
ACVRL1C34RTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(May 24, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr12:52309906
GRCh38:
Chr12:51916122
ACVRL1E191Q, E275Q, E379QTelangiectasia, hereditary hemorrhagic, type 2Uncertain significance
(Sep 2, 2021)
criteria provided, single submitter
53.
GRCh37:
Chr12:52307858
GRCh38:
Chr12:51914074
ACVRL1Cardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2Likely pathogenic
(Jan 3, 2023)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr12:52307091
GRCh38:
Chr12:51913307
ACVRL1C90WCardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2Pathogenic/Likely pathogenic
(Jul 4, 2022)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr12:52309241
GRCh38:
Chr12:51915457
ACVRL1Cardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Sep 15, 2022)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr12:52309272
GRCh38:
Chr12:51915488
ACVRL1I346F, I158F, I242FCardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2Uncertain significance
(Jun 30, 2021)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr12:52312797
GRCh38:
Chr12:51919013
ACVRL1F321L, F237L, F373L, F425L, F255LTelangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotypePathogenic/Likely pathogenic
(Sep 24, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr12:52309102
GRCh38:
Chr12:51915318
ACVRL1L101P, L185P, L289PCardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Oct 26, 2022)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr12:52308314
GRCh38:
Chr12:51914530
ACVRL1W239*, W51*, W135*Telangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotypePathogenic
(Jul 18, 2022)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr12:52308313
GRCh38:
Chr12:51914529
ACVRL1W239*, W51*, W135*Telangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotypePathogenic
(Oct 7, 2022)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr12:52308286-52308288
GRCh38:
Chr12:51914502-51914504
ACVRL1F43del, F127del, F231delTelangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotypeUncertain significance
(Mar 11, 2022)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr12:52306922
GRCh38:
Chr12:51913138
ACVRL1C34YTelangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotypePathogenic/Likely pathogenic
(Dec 2, 2021)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr12:52307751
GRCh38:
Chr12:51913967
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotypeConflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
64.
GRCh37:
Chr12:52307529
GRCh38:
Chr12:51913745
ACVRL1S167CTelangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotypeConflicting interpretations of pathogenicity
(Oct 13, 2022)
criteria provided, conflicting interpretations
65.
GRCh37:
Chr12:52309958
GRCh38:
Chr12:51916174
ACVRL1T292I, T396I, T208ITelangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotypeUncertain significance
(Dec 17, 2022)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr12:52309917
GRCh38:
Chr12:51916133
ACVRL1Cardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Sep 17, 2022)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr12:52309273
GRCh38:
Chr12:51915489
ACVRL1I158S, I242S, I346STelangiectasia, hereditary hemorrhagic, type 2Uncertain significance
(Sep 25, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr12:52309204
GRCh38:
Chr12:51915420
ACVRL1K135T, K219T, K323TTelangiectasia, hereditary hemorrhagic, type 2Uncertain significance
(Aug 3, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr12:52308264
GRCh38:
Chr12:51914480
ACVRL1G119R, G223R, G35RTelangiectasia, hereditary hemorrhagic, type 2Uncertain significance
(Sep 1, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr12:52307463
GRCh38:
Chr12:51913679
ACVRL1R146fsTelangiectasia, hereditary hemorrhagic, type 2Pathogenic
(Feb 2, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr12:52307107
GRCh38:
Chr12:51913323
ACVRL1N96DTelangiectasia, hereditary hemorrhagic, type 2Likely pathogenic
(Oct 14, 2020)
criteria provided, single submitter
72.
GRCh37:
Chr12:52309231
GRCh38:
Chr12:51915447
ACVRL1K332RTelangiectasia, hereditary hemorrhagic, type 2Likely pathogenic
(Apr 8, 2022)
no assertion criteria provided
73.
GRCh37:
Chr12:52313145-52313146
GRCh38:
Chr12:51919361-51919362
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Benign
(Mar 30, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr12:52308367
GRCh38:
Chr12:51914583
ACVRL1L257PTelangiectasia, hereditary hemorrhagic, type 2Uncertain significance
(Apr 22, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr12:52306326
GRCh38:
Chr12:51912542
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Benign
(Oct 3, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr12:52309250
GRCh38:
Chr12:51915466
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Apr 30, 2021)
criteria provided, single submitter
77.
GRCh37:
Chr12:52308261
GRCh38:
Chr12:51914477
ACVRL1H222YTelangiectasia, hereditary hemorrhagic, type 2Likely benign
(Dec 19, 2021)
criteria provided, single submitter
78.
GRCh37:
Chr12:52307540
GRCh38:
Chr12:51913756
ACVRL1D171NTelangiectasia, hereditary hemorrhagic, type 2, not providedConflicting interpretations of pathogenicity
(Sep 23, 2022)
criteria provided, conflicting interpretations
79.
GRCh37:
Chr12:52314615
GRCh38:
Chr12:51920831
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Dec 1, 2020)
criteria provided, single submitter
80.
GRCh37:
Chr12:52307401
GRCh38:
Chr12:51913617
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Nov 26, 2020)
criteria provided, single submitter
81.
GRCh37:
Chr12:52309049
GRCh38:
Chr12:51915265
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Feb 13, 2021)
criteria provided, single submitter
82.
GRCh37:
Chr12:52307331
GRCh38:
Chr12:51913547
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Dec 10, 2021)
criteria provided, single submitter
83.
GRCh37:
Chr12:52314571
GRCh38:
Chr12:51920787
ACVRL1R469QTelangiectasia, hereditary hemorrhagic, type 2Likely benign
(Aug 31, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr12:52309082
GRCh38:
Chr12:51915298
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Sep 23, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr12:52309169
GRCh38:
Chr12:51915385
ACVRL1Cardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Sep 18, 2022)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr12:52308257
GRCh38:
Chr12:51914473
ACVRL1L220FTelangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotypeLikely benign
(Jan 26, 2022)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr12:52307067
GRCh38:
Chr12:51913283
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Jan 29, 2021)
criteria provided, single submitter
88.
GRCh37:
Chr12:52309827
GRCh38:
Chr12:51916043
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Aug 12, 2021)
criteria provided, single submitter
89.
GRCh37:
Chr12:52306911
GRCh38:
Chr12:51913127
ACVRL1Cardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Dec 9, 2022)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr12:52306941
GRCh38:
Chr12:51913157
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Aug 14, 2021)
criteria provided, single submitter
91.
GRCh37:
Chr12:52314629
GRCh38:
Chr12:51920845
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Apr 14, 2021)
criteria provided, single submitter
92.
GRCh37:
Chr12:52306276
GRCh38:
Chr12:51912492
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(May 12, 2021)
criteria provided, single submitter
93.
GRCh37:
Chr12:52307781
GRCh38:
Chr12:51913997
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely benign
(Feb 12, 2021)
criteria provided, single submitter
94.
GRCh37:
Chr12:52312856-52312857
GRCh38:
Chr12:51919072-51919073
ACVRL1D445fsTelangiectasia, hereditary hemorrhagic, type 2Likely pathogenic
(Feb 25, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr12:52312768
GRCh38:
Chr12:51918984
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely pathogenic
(Jun 7, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr12:52308355
GRCh38:
Chr12:51914571
ACVRL1H253RTelangiectasia, hereditary hemorrhagic, type 2Uncertain significance
(Aug 27, 2021)
criteria provided, single submitter
97.
GRCh37:
Chr12:52314616
GRCh38:
Chr12:51920832
ACVRL1R484PTelangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotypeLikely pathogenic
(Aug 26, 2021)
criteria provided, multiple submitters, no conflicts
98.
GRCh37:
Chr12:52312868
GRCh38:
Chr12:51919084
ACVRL1P449LCardiovascular phenotype, not provided, Telangiectasia, hereditary hemorrhagic, type 2
Conflicting interpretations of pathogenicity
(Jul 7, 2022)
criteria provided, conflicting interpretations
99.
GRCh37:
Chr12:52306969
GRCh38:
Chr12:51913185
ACVRL1W50GTelangiectasia, hereditary hemorrhagic, type 2Likely pathogenic
(Apr 28, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr12:52309819
GRCh38:
Chr12:51916035
ACVRL1Telangiectasia, hereditary hemorrhagic, type 2Likely pathogenic
(Aug 12, 2021)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination